Sp1 is necessary for gene activation of Adamts17 by estrogen

Zanhui Jia1, Shuping Gao, Nadira M'Rabet

  • 1Clinic of Gynecological Endocrinology and Reproductive Medicine, University of Basel, Spitalstrasse 21, CH-4031, Basel, Switzerland; Department of Biomedicine, University of Basel, Hebelstrasse 20, CH-4031, Basel, Switzerland; Department of Gynecology and Obstetrics, Second Hospital of Jilin University, Changchun City, Jilin Province, P.R. China.

Insights

Adamts17 (ADAM metallopeptidase domain 17) knockdown inhibits breast cancer growth and induces apoptosis. Estrogen rapidly induces Adamts17, regulated by Sp1 and epigenetic factors, suggesting Adamts17 promotes cancer survival.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Biochemistry

Background:

  • Adamts17 (ADAM metallopeptidase domain 17) is a secreted metalloproteinase.
  • Its role in cancer, particularly breast cancer, is not fully understood.

Purpose of the Study:

  • To investigate the function of Adamts17 in breast cancer cell growth and survival.
  • To elucidate the regulatory mechanisms of Adamts17 gene expression.

Main Methods:

  • siRNA knockdown of Adamts17, Sp1, and Myc in breast cancer cells.
  • Reporter assays to analyze promoter activity.
  • Treatment with histone deacetylase (HDAC) and methylase inhibitors.
  • Meta-analysis of Oncomine microarray data.

Main Results:

  • Knockdown of Adamts17 inhibited breast cancer cell growth and induced apoptosis.
  • Estrogen rapidly induced Adamts17 expression, dependent on Sp1 transcription factor.
  • Sp1 binding elements may be located in intronic regions, contributing to estrogen responsiveness.
  • Sp1 and Myc binding in the proximal promoter influenced basal Adamts17 expression.
  • HDAC and methylase inhibitors increased Adamts17 expression, suggesting epigenetic regulation.
  • Higher Adamts17 expression was observed in human breast ductal carcinoma subtypes.
  • Elevated Adamts17 expression correlated inversely with patient survival.

Conclusions:

  • Adamts17 plays a role in promoting breast cancer cell growth and survival.
  • Adamts17 expression is regulated by estrogen, Sp1, and epigenetic modifications.
  • Adamts17 represents a potential therapeutic target for breast cancer.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.5K